This statement was released by the United States Council for International Business (USCIB). For the full original press release click here.
New York, N.Y., March 03, 2021—Peter Robinson, president and chief executive of the United States Council for International Business (USCIB), which represents many of America’s leading global companies, released a statement today in reaction to President Joe Biden’s announcement on March 2 that Merck will help make Johnson & Johnson’s single-shot COVID-19 vaccine:
“We at USCIB commend our member companies J&J and Merck for collaborating in the fight against the COVID-19 pandemic. The partnership between these two companies and the commitment of their CEOs, both of which are USCIB Trustees, brings us a great amount of pride and excitement. Over the years, our motto at USCIB has been ‘Global Business Leadership At Work’ and we are pleased that our member companies have been demonstrating that and leading by example.
“The USCIB Foundation meanwhile is also building momentum on our most recent initiative – Business Partners to CONVINCE – a global, multi-sector effort to empower a ‘vaccine-literate’ public, led by employers as trusted messengers to their employees and based on trust in science and aligned commitment to future COVID-19 vaccines and other novel countermeasures.”